Ronald B. Schifman, MD

Professor, Pathology
Associate Professor, Pathology
Director, Clinical Pathology
  • University of Kansas School of Medicine, Kansas City, Kansas, 1976 (M.D.)
  • University of Arizona Health Sciences Center, Tucson, Arizona , 1997 (Internship)
  • University of Arizona Health Sciences Center, Tucson, Arizona, 1978-1980 (Residency, Anatomic/Clinical Pathology)
Honors and Awards: 
  • Consultant, Department of Health and Human Services, Division of Maternal and Child Health, 1985 - present
  • Member, Quality Assurance Committee, College of American Pathologists, 1985-present
  • Consultant, Centers for Disease Control NHANES III Survey Program, 1987
  • Member, Council on Microbiology, American Society of Clinical Pathologists, 1987-present
  • Member, Ad hoc Expert Panel, FDA Center for Food Safety and Applied Nutrition, 1989
Major Areas of Research Interest: 
  • Viral hepatitis B.
  • Development of National Quality Assurance Programs in Pathology
  • Antimicrobial susceptibility testing
  • Antimicrobial utilization
Student Opportunities Through Research: 

The student researcher will learn basic susceptibility techniques used in the clinical microbiology laboratory. In addition, the student will perform bioluminescence measurements to study antimicrobial susceptibility testing. This experience will be valuable to the student who is interested in diagnostic microbiology and infectious diseases.

Selected Publications: 

Zarbo RJ. Jones BA. Friedberg RC. Valenstein PN. Renner SW. Schifman RB. Walsh MK. Howanitz PJ. Q-tracks: a College of American Pathologists program of continuous laboratory monitoring and longitudinal tracking. Archives of Pathology & Laboratory Medicine. 126(9):1036-44, 2002.

Schifman RB. Strategies for quality management in clinical microbiology. Clinics in Laboratory Medicine. 15(2):437-46, 1995.

McLaughlin WJ. Schifman RB. Ryan KJ. Manriquez GM. Bhattacharyya AK. Dunn BE. Weinstein RS. Telemicrobiology: feasibility study. Telemedicine Journal. 4(1):11-7, 1998.

Wednesday, March 7, 2018